Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events early dialog nice eunethta uk perspective politically uncertain era
… of symptoms, impacts, and treatment priorities from the early groups. Armed with this data, we developed a survey …
… to help commercialize your products. Located in the US, UK, Germany, Spain, and Sweden , our team of over 60 health …
… Warttig Market Access and Outcomes Strategy Telecommuter - UK DHealthPsy, Health Psychology Staffordshire University, … at the National Institute of Health and Care Excellence (NICE) where she led the development of NICE guidelines and NICE HTA’s in a range of topic areas, and …
… regulators, providers, and patients. Who can benefit from early market access planning for rare disease therapies? …
ENCePP’s 10th Year: A Story of Diversity and Collaboration Share on: February 5, 2018 The goal of the European Network of Centers for Pharmacoepidemiology and Pharmacovigilance (ENCePP) is to facilitate independent and transparent post-authorization …
… the brightest, most talented, hard-working, and genuinely nice people on our team. But wouldn’t you rather meet them …
… and belonging. Read more about our culture from the perspective of our employees below. If this approach to …
… key considerations for manufacturers planning to develop early dossiers for their products. Takeaway 1: Determine … can have different objectives for developing an early dossier. One manufacturer may consider it an … it as an opportunity to present as much clinical data as early as possible. These objectives may also differ depending …
… Hasan Basarir Health Economics Telecommuter - UK PhD, Economics MSc, Economics and Finance University of … and has served as a member of an Evidence Review Group for NICE in the UK. He has worked in therapeutic areas including diabetes, …
… Faisal Latif Telecommuter - UK MSc, International Health Policy with Health Economics …